<html>
<head>PUBMED IDs for Sp110</head>
<body bgcolor='#C5F0F2'><h1>Sp110</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10913195/'>Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator.</a> July 27  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/14559998/'>Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus.</a> October 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15308735/'>Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expression.</a> August 17  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16648851/'>Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease.</a> May 2  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16816019/'>No associations of human pulmonary tuberculosis with Sp110 variants.</a> July 4  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17883869/'>Sp110 transcription is induced and required by Anaplasma phagocytophilum for infection of human promyelocytic cells.</a> September 22  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19520608/'>Gene expression in HIV-1/Mycobacterium tuberculosis co-infected macrophages is dominated by M. tuberculosis.</a> December 25  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/22982295/'>Hepatic veno-occlusive disease with immunodeficiency (VODI): first reported case in the U.S. and identification of a unique mutation in Sp110.</a> January 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/26912204/'>The Transcriptional Foundations of Sp110-mediated Macrophage (RAW264.7) Resistance to Mycobacterium tuberculosis H37Ra.</a> December 20  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26995495/'>Molecular characterization of Sp110 gene in pigs.</a> January 27  2016<br></body></html>
